Gastrointestinal carcinoid tumors, a rare subset among digestive tract malignancies, pose unique challenges in cancer research. Emerging studies spotlight their intricate molecular landscape and varied clinical behaviors, propelling efforts to unlock targeted therapies. Innovations in imaging technology play a pivotal role, facilitating early diagnosis and accurate staging for tailored treatment plans. Collaborative interdisciplinary endeavors underscore the quest for personalized approaches, uniting oncologists, pathologists, and researchers in the pursuit of enhanced patient outcomes. As incidence rates climb, understanding the nuanced nature of these tumors becomes paramount, driving forward the frontier of gastrointestinal oncology.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States